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preconditioning and regeneration of the
adult zebrafish heart
Anne-Sophie de Preux Charles†, Thomas Bise†, Felix Baier, Jan Marro
and Anna Jaz´win´ska
Department of Biology, University of Fribourg, Chemin du Muse´e 10, 1700 Fribourg, Switzerland
The adult heart is able to activate cardioprotective programmes and mod-
ifies its architecture in response to physiological or pathological changes.
While mammalian cardiac remodelling often involves hypertrophic expan-
sion, the adult zebrafish heart exploits hyperplastic growth. This capacity
depends on the responsiveness of zebrafish cardiomyocytes to mitogenic
signals throughout their entire life. Here, we have examined the role
of inflammation on the stimulation of cell cycle activity in the context of
heart preconditioning and regeneration. We used thoracotomy as a cardiac
preconditioning model and cryoinjury as a model of cardiac infarction in
the adult zebrafish. First, we performed a spatio-temporal characterization
of leucocytes and cycling cardiac cells after thoracotomy. This analysis
revealed a concomitance between the infiltration of inflammatory cells and
the stimulation of the mitotic activity. However, decreasing the immune
response using clodronate liposome injection, PLX3397 treatment or anti-
inflammatory drugs surprisingly had no effect on the re-entry of cardiac
cells into the cell cycle. In contrast, reducing inflammation using the same
strategies after cryoinjury strongly impaired cardiac cell mitotic activity
and the regenerative process. Taken together, our results show that, while
the immune response is not necessary to induce cell-cycle activity in intact
preconditioned hearts, inflammation is required for the regeneration of
injured hearts in zebrafish.1. Introduction
Preconditioning refers to the induction of cellular survival and pro-regenerative
programmes by brief exposure to non-lethal noxious stimuli, which sub-
sequently increase the resistance of tissues to further harmful injuries. Our
laboratory has recently developed two independent models of cardiac precon-
ditioning in the adult zebrafish. In the first model, we used an incision through
the chest (thoracotomy) as a preconditioning stimulus. Our second model used
a more remote stimulus. In this case, cardioprotection is elicited by the intraper-
itoneal injection of immunogenic particles [1]. In contrast to mammalian
models of cardiac preconditioning, thoracotomy or injection of immunogenic
particles not only invoked the expression of cardioprotective genes but also
increased the mitotic activity in the adult ventricle, leading to a long-term archi-
tectural modification of the ventricle, illustrated by a thickening of the compact
myocardium wall [1]. Similar to mammals, preconditioning of the adult zebra-
fish heart enhances regeneration. When fish are subjected to preconditioning
within the week preceding the heart injury, the re-entry of cardiomyocytes
(CMs) into the cell cycle is more efficient; CM dedifferentiation and cell survival
are promoted [1].
Although preconditioning has proved to be remarkably reproducible in
human ischaemic disorders, the underlying triggering mechanisms are still
unclear [2,3]. The current hypothesis suggests that both neural and humoral
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2aspects are at stake to elicit this phenomenon. The humoral
hypothesis is supported by studies performed in rabbits or
rats, where the protected phenotype could be transferred
frompreconditioned to naive individuals by blood transfusion
[4,5]. Several effector molecules, such as bradykinin, hypoxia-
inducible factor 1a (HIF-1a) or stromal-derived factor 1a
(SDF-1a), have been identified by proteomic approaches;
however, their use as a preconditioning factor did not give
convincing results [6]. An explanation for these disappointing
outcomes might come from the multifactorial nature of pre-
conditioning [2,6,7]. For that reason, studying an upstream
stimulus acting at a systemic level, such as inflammation,
could be of great interest to reach a better understanding of
the mechanisms underlying preconditioning.
In contrast to mammals, zebrafish are able to efficiently
repair their damaged myocardium. Fibrosis is only transient,
and the injured cardiac muscle is fully reconstituted by new
CMs within 30–60 days [8,9]. This spectacular regenerative
capacity depends on the remarkable responsiveness of zebra-
fish CMs to mitogenic signals throughout their adult life
[8,10]. Even though many local paracrine factors promoting
CM proliferation after heart injury have already been
described [11–16], the role of systemic factors such as inner-
vation or inflammation on zebrafish CM proliferation has
only recently been addressed [17–19].
The innate immune system, which comprises neutrophils
and macrophages, is the first defence against harmful factors
and rapidly responds to signals released from damaged tis-
sues. According to current evidence, preconditioning
stimuli can activate resident phagocytic cells and cause the
release of pro-inflammatory cytokines to induce the pro-
survival programmes [20,21]. Nevertheless, the role of the
immune response on heart preconditioning is still under
debate. Contradictory results have been obtained so far,
showing both a pro- and an anti-inflammatory effect of
remote cardiac conditioning [22]. The exact role of inflam-
mation on the induction of a protected phenotype in the
heart needs therefore to be further investigated. Interestingly,
the function of the immune response is also under debate in
the context of cardiac injury. Decreasing inflammation has
led to both beneficial and damaging effects on cardiac
repair programmes [23,24].
In this study, we proposed to examine the role of inflam-
mation in both heart preconditioning and regeneration. In the
first part of the study, we used a thoracotomy model to inves-
tigate the mechanisms of heart preconditioning after a
systemic challenge without any physical damage to the myo-
cardium. In contrast to mammals, the systemic reaction set in
motion after preconditioning in the zebrafish promoted the
re-entry of cardiac cells into the cell cycle and led to long-
term morphological modifications of the myocardium [1].
To address the involvement of inflammation in this phenom-
enon, we first characterized the spatio-temporal dynamics of
leucocytes and mitotic cardiac cells after thoracotomy. We
observed a correlation between the CM cell-cycle activity
and the presence of leucocytes in preconditioned hearts.
Unexpectedly, decreasing the immune response after thora-
cotomy by means of several distinct approaches had no
effect on the re-entry of cardiac cells into the cell cycle, indi-
cating that leucocytes do not act directly to promote the
mitotic activity observed in preconditioned intact hearts. In
the second part, we used cryoinjury as a model of cardiac
infarction to assess the role of inflammation in cardiacregeneration. In regenerating hearts, we observed a similar
correlation between the presence of leucocytes and cell-
cycle activity to that after cardiac preconditioning. However,
the analysis of cryoinjured hearts revealed an important det-
rimental impact of a decreased immune response on both cell
mitotic activity and repair of the cryoinjured area, suggesting
that immune cells are in this context a prerequisite for an
efficient regeneration.2. Material and methods
2.1. Animal procedures
This work was performed with fully grown adult fish at the
age of 12–24 months. Wild-type fish were AB (Oregon),
transgenic fish lines were cmlc2:DsRed2-nuc, CD41:EGFP
and mpeg1:EGFP [25–27]. Before every procedure, fish were
anaesthetized in 0.1% tricaine (Sigma-Aldrich). Chest
wound injuries were performed as described previously
[9,28]. Briefly, fish were placed ventral side up on a damp
sponge, and a small incision was made through the thorax
skin with iridectomy scissors. Cryoinjuries were performed
as described previously [9,28]. The phagocyte population
was depleted by intraperitoneal injection of 5 ml suspension
of clodronate- (5 mg ml21) or PBS-containing liposomes
(Encapsula NanoSciences LLC) 24 h before the thoracotomy
or cryoinjury procedure. The injection was repeated at 4
days post-thoracotomy (dpt) or at 4 days post-cryoinjury
(dpci) to ensure a constant low level of phagocytes in clodro-
some-injected fish. The inflammatory response was blocked
by immersing fish in 0.05% DMSO, 500 nM PLX3397 (Plexxi-
kon), 5 mM flumethasone (Santa Cruz Biotechnologies) or
10 mM pranlukast (Sigma-Aldrich). For all drug treatments,
fish were immersed 3 days before the thoracotomy or the
cryoinjury and maintained under those conditions for the fol-
lowing 7 days. During all treatments, fish were fed, and
solutions were changed every third day. For L-plastin stain-
ing, 5 ml of 2% paraformaldehyde was injected into the
thorax of euthanized animals 15 min before heart collection.
This prefixation was performed to avoid corruption of the
results by immune cells that are carried in the blood and
that adhere to the surface of the ventricle just at the
moment of heart collection. The cantonal veterinary office
of Fribourg approved this experimental research on animals.
2.2. Immunohistochemistry and histology
At the end of each experiment, the hearts were collected and
fixed overnight at 48C in 2% paraformaldehyde. They were
then rinsed in PBS and equilibrated in 30% sucrose before
embedding in tissue-Tek OCT compound (Sakura Finetek
Europe B.V.) and cryosectioned at a thickness of 16 mm. The
immunohistochemistry procedures were performed as pre-
viously described [9]. The following primary antibodies were
used: chicken anti-L-plastin at 1 : 500 (kindly provided by
P. Martin, Bristol) [29], rabbit anti-MCM5 at 1 : 5000 (kindly
provided by Soojin Ryu, Heidelberg), rabbit anti-DsRed
(Clonetech, 632496) at 1 : 200 and mouse anti-tropomyosin
(developed by Jim Jung-Ching Lin and obtained from the
Developmental Studies Hybridoma Bank, University of
Iowa). The Alexa-Fluor-conjugated secondary antibodies
(Jackson Immunoresearch) were used at 1 : 500, and DAPI
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Figure 1. CM proliferation is correlated with the distribution of phagocytic immune cells. (a,b) Representative sections of the hearts reveal a few L-plastin-positive
cells in uninjured fish in comparison to fish at 7 days post-thoracotomy (dpt) with the abundant L-plastin staining in the compact myocardium. A white dashed line
separates compact (comp. MC) and trabecular (trab. MC) myocardium. (c,d ) Representative sections of the heart of cmlc:DsRed2-nuc transgenic fish (red, marker of
CM nuclei) labelled with the G1/S-phase marker MCM5 (green) reveal an increased mitotic activity at 7 dpt. Arrows indicate double-positive cells. (e) Quantification
of the L-plastin-positive area (white circles) and of the number of proliferative CMs (black circles) in sections of uninjured hearts, and at 1, 4, 7, 14, 21 and 30 dpt.
( f,g) Quantification of L-plastin-labelled leucocytes and MCM5-positive CMs in the two distinct myocardium compartments reveals a spatial correlation of both
distributions at 7 dpt. (n  4 hearts; 2 sections per heart; ***p, 0.001).
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3was used at 1 : 2000. Aniline blue, acid Fuchsin and Orange G
(AFOG) staining were performed as previously described [16].
2.3. Image analysis and quantification
After antibody staining, cardiac tissue imagingwas performed
at 20 magnification with confocal microscopes (Leica TCS-
SP5 and Leica TCS-SPE-II). At least three different pictures
were taken for each heart. n represents the number of fish
used in the experiment. IMAGEJ software was used to perform
the subsequent image analysis. The number of proliferating
non-CM nuclei was obtained by subtracting the number of
cmlc2:DsRed2-nuc-positive nuclei from the total number of
nuclei. To quantify the number of proliferating nuclei, the
images of cell cycle marker (MCM5) were superimposed
with the images of nuclei markers (DAPI; cmlc2:DsRed2-nuc).
L-plastin-positive area was normalized to the total area of
the ventricle. All results are expressed as the mean+ standard
error of the mean. Unless specified, p-values were obtained by
performing t-tests. Regeneration scores were assigned to 30
dpci regenerating hearts based on AFOG histological staining,
which differentiates between the myocardium, fibrin-rich
tissue and collagen fibres [17]. The scores follow the followingcriteria: complete regeneration ¼ absence or residual collagen
fibres; partial regeneration ¼ advanced regeneration with
persisting collagen fibres; blocked regeneration ¼ large
injured area containing provisional fibrotic matrix. Statistical
significance was obtained by Fisher’s exact test.
2.4. Protein homology analysis
To test if the binding pockets of c-Kit and c-FMS proteins
are conserved through vertebrates, using T-Coffee [30] we
aligned the sequences of Homo sapiens c-FMS (NP_005202.2)
and c-Kit (NP_000213.1) with their Danio rerio orthologues
c-FMS (NP_571747.1), c-Kita (NP_571128.1) and c-Kitb
(NP_001137390.1).3. Results
3.1. Cardiomyocyte proliferation correlates with the
presence of leucocytes after thoracotomy
We recently established thoracotomy as a model of heart pre-
conditioning in the adult zebrafish [1]. While leaving the
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Figure 2. Depleting phagocytes by injection of clodronate liposomes does not affect CM proliferation. (a,b) The impact of control and clodronate liposome injection on
the presence of leucocytes was tested by labelling the hearts of mpeg1:GFP transgenic fish (green) with L-plastin (red). (c,d ) CM proliferation was quantified by measur-
ing the number of CMs co-expressing DsRed2-nuc (red) and MCM5 (green). Double-positive cells are indicated with arrows. (e,f ) Quantification of L-plastin- and
mpeg1:GFP-positive area. (g,h) Quantification of proliferative CM and non-CM nuclei. (n  4 hearts; 2 sections per heart; ***p, 0.001; n.s., non-significant).
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4heart untouched, the thoracotomy procedure exposes the car-
diac structures to many aggressions, such as mechanical
and osmotic stress or bacterial contamination, triggering an
inflammatory response. To test whether inflammation
might cause the increased CM mitotic activity seen after thor-
acic incision, we decided to characterize the distribution of
leucocytes after thoracotomy. For this, we used an antibody
against L-plastin, a leucocyte-specific actin-bundling protein
[31]. To validate L-plastin as a suitable leucocyte marker,
transgenic reporter lines for specific haematopoietic lineages
were used: mpeg1:EGFP fish were used to visualize macro-
phages, whereas CD41:EGPF fish were selected to identify
thrombocytes [26,27]. Remarkably, all mpeg1:EGFP-positive
cells were L-plastin-positive (electronic supplementary
material, figure S1a). At 7 dpt, mpeg1:EGFP-positive cells
accounted for approximately 10% of L-plastin-positive cells
(data not shown). In contrast, no overlap was found between
L-plastin staining and the thrombocytes marker CD41:EGFP(electronic supplementary material, figure S1b). Moreover,
no L-plastin was detected in the blood clots occasionally
trapped in the lumen of the heart (electronic supplementary
material, figure S1c). In summary, these co-stainings
showed that L-plastin does not label thrombocytes or
erythrocytes, but colocalizes with the specific leucocyte trans-
genic reporter, mpeg1. We concluded that L-plastin is a valid
leucocyte marker.
To detect any correlation between mitotic activity and
inflammation, we performed a spatio-temporal description
of the distribution of leucocytes and cycling CMs after thora-
cotomy (figure 1). The presence of leucocytes was increased
rapidly after thoracotomy to peak at 4 dpt. The inflammatory
response then slowly decreased to reach its normal level by
30 dpt (figure 1e). CM cell-cycle activity was assessed by
counting the number of MCM5-positive CMs. Remarkably,
after thoracic incision, CM mitotic activity slowly increased
to reach a plateau between 7 and 14 dpt with approximately
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55% of cycling CMs, and finally decreased to reach its normal
level at 30 dpt (figure 1e).
The zebrafish ventricle is composed of two distinct com-
partments: a dense cortical layer (compact myocardium) that
surrounds a spongy inner structure (trabecular myocardium)
[32]. We have previously described that most cycling CMs
are located in the compact myocardium after preconditioning.Based on this observation, we asked whether leucocytes were
evenly scattered through both myocardial compartments.
Strikingly, we observed that leucocytes accumulated in the
compact myocardium (figure 1a,b,f ), where cycling CMs
were observed (figure 1c,d,g). The concomitance of the inflam-
matory response and of the entry of CMs into the cell cycle
suggests a correlation between these two processes.
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63.2. Leucocyte accumulation is not required to stimulate
cardiomyocyte proliferation after thoracotomy
To test the role of the leucocytes in the initiation of the mitotic
response induced in our cardiac preconditioning model, we
applied diverse experimental approaches to modulate the
immune response. First, the overall phagocyte population
was depleted by an intraperitoneal injection of clodrosomes,
which are cytotoxic clodronate encapsulated liposomes, one
day before the thoracotomy and at 4 dpt. In the mouse
heart, this method specifically reduces the cardiac mono-
nuclear phagocyte population without altering neutrophils[23]. We found that clodrosome-injected fish displayed a
fourfold reduction of L-plastin-positive area in the heart at
7 dpt, compared with fish injected with control liposomes
(figure 2a,b,e). Similarly, very few mpeg1:EGFP-positive cells
could be detected after clodrosome injections (figure 2a,b,f ).
These results support clodrosome injection as a valid
method to deplete phagocytes in the zebrafish. Surprisingly,
this decreased immune response had no effect on the
cell-cycle activity of CM or non-CM nuclei (figure 2c,d,g,h).
In a second approach, the immune response after thoracot-
omy was modulated using PLX3397, a selective inhibitor of
c-Fms/CSF1R and c-Kit tyrosine kinases. These receptors
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7regulate theproliferation ofmultipotent haematopoietic progeni-
tor cells and their myeloid differentiation [33]. In mammals,
PLX3397 has been shown to inhibit macrophage migration and
proliferationand todecrease theproductionofpro-inflammatory
cytokines [34]. To verify if PLX3397might be an efficient c-Fms/
CSF1R and c-Kit inhibitor in zebrafish, we aligned theH. sapiensand Danio rerio c-Fms and c-Kit orthologue proteins (electronic
supplementarymaterial, figure S2).We focused this comparison
on the region that interacts with PLX3397 (H. sapiens c-Kit L521–
L865;H. sapiens c-Fms L514–K870) [35]. Both proteins werewell
conserved between these two species, and all residues making
direct contact with the inhibitor were preserved, suggesting
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8that PLX3397 might work as a specific c-Fms/CSF1R and c-Kit
inhibitoralso in zebrafish.Accordingly, PLX3397-treated fishdis-
played a threefold decrease of the presence of leucocytes in the
heart at 7 dpt (figure 3a,b,e). Despite this, CM cell-cycle activity
was not affected (figure 3c,d,f,g).
Because both methods, clodronate liposomes and
PLX3397, mainly affect the macrophage lineage, widely
acting anti-inflammatory drugs were used to exclude any
role of other immune mechanisms in the induction of CM
proliferation (figure 4). Even so, reducing the immune
response using flumethasone (figure 4b) or pranlukast
(figure 4c) did not affect the rate of re-entry into the cell
cycle (figure 4d,e).Taken together, we concluded that cardiac precondition-
ing is accompanied by an accumulation of leucocytes in
the uninjured myocardium. However, the presence and
function of these immune cells are not essential for triggering
cell-cycle progression in the intact zebrafish heart.3.3. Cycling cardiomyocytes are associated with the
presence of leucocytes after cryoinjury
Although inflammation is associated but not required for heart
conditioning, we decided to address the role of leucocytes
during heart regeneration. To induce myocardial injury, we
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9applied the cryoinjury model, in which approximately 20% of
the ventricle is damaged by exposure to a precooled metal
probe [28]. Within the first week after the procedure, the
damaged part of the myocardium becomes replaced with provi-
sional fibrotic tissue. Within four weeks, this fibrotic tissue
undergoes remodelling to repair the injured ventricle and pro-
gressively withdraws to give space for the regenerating
myocardium [36]. After cryoinjury, CM mitotic activity slowly
increased to reach a plateau between 7 and 21 dpci with approxi-
mately 10% of proliferating CMs, and finally decreased to reach
its normal level at 60 dpci [9]. The complete restoration of the
cardiac tissue is achieved in four to eight weeks [9,37]. To deter-
mine the involvement of immune response in heart regeneration,
we analysed the distribution of L-plastin-expressing cells at
different regenerative phases. Shortly after cryoinjury, at 1 and
4 dpci, leucocytes infiltrated the myocardium and abundantly
accumulated in the post-injury zone, consistent with the
stimulation of immune response in the damaged tissue
(figure 5a,b). At 14 dpci, the number of L-plastin-positive cells
declined as regeneration progressed (figure 5b).3.4. Leucocytes promote the re-entry of cardiomyocytes
into the cell cycle after cryoinjury
To assess the role of inflammation on CM cell-cycle activity
after ventricular cryoinjury, we applied the same experimentalstrategies as after thoracotomy.Again,wewere able to efficiently
reduce the phagocyte population with PLX3397 treatment or
intraperitoneal injection of clodrosomes, as illustrated by L-plas-
tin staining (figure 5c– f). With both strategies, more than a
twofold decrease of leucocytes was observed in the hearts at 7
days after cryoinjury (figure 5g,h). In this context, however, the
reduced immune response strongly suppressed the stimulation
of the mitotic activity (figure 6a,b,d,e and figure 7). This effect
was observed for both CM and non-CM nuclei (figures 6d,e
and 7c,d). Likewise, treating fish with the wide anti-inflamma-
tory drug flumethasone severely impaired the re-entry of
cardiac cells into the cell cycle at 7 dpci (figure 6c,d,e).3.5. The deposition of a transient scar is dependent on
leucocytes after cryoinjury
Moreover, fish treated with flumethasone for one month after
cryoinjury clearly exhibited a blocked regenerative process,
as revealed by histological staining (figure 8a–e). In the
majority of control fish, regeneration was almost completed
(figure 8d– f ). At this stage, fibrin deposits were completely
resolved, and only small size scars retaining collagen fibres
were observed (figure 8a–c). In contrast, the flumethasone-
treated fish displayed blocked regeneration (figure 8d,e,f ),
which was reminiscent of the early regenerative phase, such
as 4 dpci (figure 8g). Fibrin-like material persisted in the
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10cryoinjured areas, and the deposition of a collagen network
necessary to support themigration of the newly formed cardiac
cells was severely impaired (figure 8e). To exclude any side
effect of the flumethasone treatment, we decided to validate
our observations using the clodronate liposome approach.
For this, fishwere injectedwith control or clodronate liposomes
24 h before the cryoinjury procedure. Liposome injectionswere
then repeated every 4 days for 2 weeks. Again, an impairment
of regeneration was found in fish in which the immune
response was blocked by clodronate liposomes (data not
shown), confirming a specific role of leucocytes in the initiation
of cardiac healing after injury. Taken together, our results
demonstrate thus that the key regenerative processes of transi-
ent scar deposition and CM proliferation are dependent on the
appropriate immune response after heart injury.4. Discussion
In mammalian studies, conflicting data have been obtained
so far on the role of inflammation on heart preconditioning[22]. For instance, it has been demonstrated that a brief
forearm ischaemia suppresses pro-inflammatory genes
expression in circulating human leucocytes [38], whereas
neutrophil adhesion and phagocytosis are reduced [39]. At
the same time, an increased production of tumour necrosis
factor-a, interleukin-1b and -8 has been detected in patients
subjected to remote ischaemic preconditioning before cardio-
pulmonary bypass [40]. Further studies are therefore
needed to precisely define the role of inflammation during
cardiac preconditioning.
To address this question in the zebrafish, we first charac-
terized the spatio-temporal dynamics of the immune
response after thoracotomy. We observed a correlation
between the presence of inflammatory cells and mitotic
nuclei after heart preconditioning, suggesting a link between
these two processes. We used two distinct strategies that
effectively depleted the macrophage population and two
different immunosuppressive drugs. None of these tech-
niques, however, had an effect on cardiac cell proliferation.
Thus, leucocytes are not necessary to induce proliferation of
cardiac cells in the context of heart preconditioning.
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Open
Biol.6:160102
11In contrast to this result, the immune response is necess-
ary for mitotic activity, the transient scar deposition and
heart regeneration after cryoinjury. These results are consist-
ent with previously published studies. In neonatal mice,
injections of liposomal clodronate robustly impair heart
regeneration after myocardial infarction [23,24]. Likewise,
inhibiting phagocyte recruitment with the glucocorticoid
beclomethasone strongly reduces zebrafish heart regenerative
capacities after ventricular resection [18]. Taken together,
these observations highlight the importance of leucocytes in
the context of a regenerative process, where the immune
response cleans the damaged area and creates a favourable
environment for tissue rebuilding. These immune cells are
essential to ensure the re-entry of cardiac cells into the cell
cycle and to pilot the injured heart towards an efficient
regeneration.
Besides, the clear phenotype observed in the cryoinjury
model confirms that the absence of effect of an altered
immune system after heart preconditioning was not due to
any dosage issues. We applied the same protocols and drug
dosage on both models. Moreover, we achieved a better
reduction of L-plastin-positive cells after preconditioning
than after cryoinjury. Therefore, we can exclude the possi-
bility that the negative results obtained with our
thoracotomy model were caused by a too gentle depletion
of the phagocytes.
In summary, we discovered that the function of inflam-
mation on the mitotic activity of cardiac cells is context-
dependent. In intact preconditioned heart, the entry of CMandnon-CMcells into the cell cycle is unresponsive to leucocyte
accumulation. These results suggest that the factors triggering
the mitotic cycle of cardiac cells are not secreted by local leuco-
cytes. In contrast, in injured hearts, phagocytic cells are key
components of the regenerative process. When their function
is depleted, cellular debris and fibrin are not efficiently cleared.
The persisting damaged tissue is likely to impair remodelling
of the post-infarcted ventricle, which directly or indirectly
blocks cardiac cell proliferation and migration to achieve
heart regeneration. Although organ regeneration requires the
inflammatory phase, the preconditioning evokes regenerative
programmes through leucocyte-independent mechanisms
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